Phase II evaluation of the sulfonylurea LY186,641 in men with hormone independent metastatic prostate cancer

George Wilding, Gerald Grindey, Nikhil Munshi, David Seitz, Lawrence Einhorn

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)203-205
Number of pages3
JournalInvestigational New Drugs
Volume11
Issue number2-3
DOIs
StatePublished - Jun 1 1993

Fingerprint

sulofenur
Hormone-Dependent Neoplasms
Sulfonylurea Compounds
Soft Tissue Neoplasms
Bone Neoplasms
Neoplasm Staging
Antineoplastic Agents
Oral Administration
Prostatic Neoplasms
Hormones

ASJC Scopus subject areas

  • Oncology
  • Pharmacology
  • Pharmacology (medical)

Cite this

Phase II evaluation of the sulfonylurea LY186,641 in men with hormone independent metastatic prostate cancer. / Wilding, George; Grindey, Gerald; Munshi, Nikhil; Seitz, David; Einhorn, Lawrence.

In: Investigational New Drugs, Vol. 11, No. 2-3, 01.06.1993, p. 203-205.

Research output: Contribution to journalArticle

Wilding, George ; Grindey, Gerald ; Munshi, Nikhil ; Seitz, David ; Einhorn, Lawrence. / Phase II evaluation of the sulfonylurea LY186,641 in men with hormone independent metastatic prostate cancer. In: Investigational New Drugs. 1993 ; Vol. 11, No. 2-3. pp. 203-205.
@article{a4979492d1534944abbaa5d5632666da,
title = "Phase II evaluation of the sulfonylurea LY186,641 in men with hormone independent metastatic prostate cancer",
author = "George Wilding and Gerald Grindey and Nikhil Munshi and David Seitz and Lawrence Einhorn",
year = "1993",
month = "6",
day = "1",
doi = "10.1007/BF00874156",
language = "English (US)",
volume = "11",
pages = "203--205",
journal = "Investigational New Drugs",
issn = "0167-6997",
publisher = "Kluwer Academic Publishers",
number = "2-3",

}

TY - JOUR

T1 - Phase II evaluation of the sulfonylurea LY186,641 in men with hormone independent metastatic prostate cancer

AU - Wilding, George

AU - Grindey, Gerald

AU - Munshi, Nikhil

AU - Seitz, David

AU - Einhorn, Lawrence

PY - 1993/6/1

Y1 - 1993/6/1

UR - http://www.scopus.com/inward/record.url?scp=0027321422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027321422&partnerID=8YFLogxK

U2 - 10.1007/BF00874156

DO - 10.1007/BF00874156

M3 - Article

C2 - 8262732

AN - SCOPUS:0027321422

VL - 11

SP - 203

EP - 205

JO - Investigational New Drugs

JF - Investigational New Drugs

SN - 0167-6997

IS - 2-3

ER -